Effect of fagaronine on cell cycle progression of human erythroleukemia K562 cells
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 12 (8) , 667-672
- https://doi.org/10.1016/0145-2126(88)90101-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The antileukemic alkaloid fagaronine and the human K 562 leukemic cells: Effects on growth and induction of erythroid differentiationLeukemia Research, 1987
- Does treatment with ARA-C in low dosage cause differentiation of leukemic cells?Blood, 1983
- Interaction of the antileukemic alkaloid, 2-hydroxy-3,8,9-trimethoxy-5-methylbenzo[c]phenanthridine (fagaronine), with nucleic acidsChemico-Biological Interactions, 1983
- Small doses of ARA-C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells?British Journal of Haematology, 1982
- Potential pre‐screening for therapeutic agents that induce differentiation in human myeloid leukemia cellsInternational Journal of Cancer, 1980
- THE DIFFERENTIATION OF MYELOID LEUKAEMIA CELLS: NEW POSSIBILITIES FOR THERAPYBritish Journal of Haematology, 1978
- Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemiaNature, 1978
- Method for the quantitative evaluation of data from flow microfluorometryComputers and Biomedical Research, 1976
- Synthesis and biological activity of some antitumor benzophenanthridinium saltsJournal of Medicinal Chemistry, 1975
- Fagaronine, a New Tumor Inhibitor Isolated from Fagara zanthoxyloides Lam. (Rutaceae)Journal of Pharmaceutical Sciences, 1972